Cleveland Biolabs (CBLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBLI | AMGN | VRTX | REGN | BMY |
| Company | Cleveland Biolabs | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.44 | 312.89 | 420.67 | 970.00 | 44.75 |
| High | 3.52 | 314.89 | 422.23 | 979.98 | 44.88 |
| Low | 3.11 | 309.82 | 417.50 | 966.85 | 44.30 |
| Last | 3.17 | 311.32 | 421.72 | 975.87 | 44.81 |
| Change | -0.25 | -1.54 | +2.73 | +7.87 | +0.07 |
| % Change | -7.31% | -0.49% | +0.65% | +0.81% | +0.16% |
| Volume | 116,400 | 1,651,702 | 584,148 | 153,911 | 4,622,963 |
| 20-Day Average Volume | 124,330 | 2,878,979 | 1,082,363 | 481,318 | 13,949,216 |
| Previous Close | 3.42 | 312.86 | 418.99 | 968.00 | 44.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.39 | 281.63 | 401.90 | 919.11 | 46.00 |
| 20-Day Raw Stochastic | 36.43% | 80.43% | 89.15% | 96.15% | 22.68% |
| 20-Day Relative Strength | 41.15% | 66.20% | 61.81% | 61.79% | 35.74% |
| Weighted Alpha | -0.71 | +34.23 | +22.56 | +31.88 | -34.68 |
| Today's Opinion | 88% Sell | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 72% Sell | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 72% Sell | 40% Sell | 24% Buy | 40% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.12% since 08/24/21 | -0.26% since 05/03/24 | +5.19% since 05/03/24 | +1.98% since 05/03/24 | +1.72% since 05/03/24 |
| Low | 3.11 on 08/31/21 | 297.52 on 05/06/24 | 394.03 on 05/07/24 | 950.27 on 05/06/24 | 43.49 on 05/09/24 |
| High | 3.55 on 08/27/21 | 314.89 on 05/10/24 | 425.65 on 05/08/24 | 979.98 on 05/10/24 | 44.88 on 05/10/24 |
| 1-Month | |||||
| %Chg | -26.28% since 07/30/21 | +16.53% since 04/10/24 | +6.11% since 04/10/24 | +4.25% since 04/10/24 | -11.03% since 04/10/24 |
| Low | 2.70 on 08/16/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 4.23 on 08/02/21 | 322.60 on 05/03/24 | 425.65 on 05/08/24 | 979.98 on 05/10/24 | 50.58 on 04/11/24 |
| 3-Month | |||||
| %Chg | -41.30% since 05/28/21 | +6.65% since 02/09/24 | -0.24% since 02/09/24 | +2.36% since 02/09/24 | -10.17% since 02/09/24 |
| Low | 2.70 on 08/16/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 7.10 on 07/06/21 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -45.25% since 02/26/21 | +16.15% since 11/10/23 | +12.91% since 11/10/23 | +22.16% since 11/10/23 | -11.59% since 11/10/23 |
| Low | 2.70 on 08/16/21 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 784.96 on 11/15/23 | 43.33 on 05/02/24 |
| High | 7.17 on 04/13/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 49,068 | 167,829,040 | 108,121,632 | 106,249,616 | 90,692,464 |
| Shares Outstanding, K | 15,479 | 536,435 | 258,053 | 109,762 | 2,027,100 |
| Annual Sales | 260,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -2,400,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -660,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.70 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 08/16/21 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 27.81 | 25.75 | 41.59 |